XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Retained Earnings [Member]
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Preferred Stock [Member]
[1]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
[1]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
[1]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Balance at Dec. 31, 2020 $ 0 $ 42,909 $ 35 $ 46,063 $ 89,007          
Balances (in shares) at Dec. 31, 2020 0 8,473,000                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income $ 0 $ 0 0 13,101 13,101          
Exercise of stock options $ 0 $ 1,204 0 0 1,204          
Exercise of stock options (in shares) 0 177,000                
Stock-based compensation $ 0 $ 318 0 0 318          
Stock-based compensation (in shares) 0 0                
Dividends on common stock $ 0 $ 0 0 (2,312) (2,312)          
Dividends on common stock (in shares) 0 0                
Other comprehensive income (loss), net $ 0 $ 0 57 0 57          
Balance at Dec. 31, 2021 $ 0 $ 44,431 92 56,852 101,375          
Balances (in shares) at Dec. 31, 2021 0 8,650,000                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income $ 0 $ 0 0 13,449 13,449          
Exercise of stock options $ 0 $ 974 0 0 974          
Exercise of stock options (in shares) 0 110,000                
Grant of restricted stock awards, net of forfeitures $ 0 $ 0 0 0 0          
Grant of restricted stock awards, net of forfeitures (in shares) 0 38,000                
Stock-based compensation $ 0 $ 289 0 0 289          
Stock-based compensation (in shares) 0 0                
Dividends on common stock $ 0 $ 0 0 (2,574) (2,574)          
Dividends on common stock (in shares) 0 0                
Other comprehensive income (loss), net $ 0 $ 0 (863) 0 (863)          
Balance at Dec. 31, 2022 $ 0 $ 45,694 (771) 67,727 $ 112,650 $ 0 $ 0 $ 0 $ (1,573) [1] $ (1,573) [1]
Balances (in shares) at Dec. 31, 2022 0 8,798,000     8,798,412 0 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accounting Standards Update [Extensible Enumeration]                 ASU 2016-13 [Member] ASU 2016-13 [Member]
Net income $ 0 $ 0 0 7,316 $ 7,316          
Exercise of stock options $ 0 $ 456 0 0 456          
Exercise of stock options (in shares) 0 54,000                
Grant of restricted stock awards, net of forfeitures $ 0 $ 0 0 0 0          
Grant of restricted stock awards, net of forfeitures (in shares) 0 23,000                
Stock-based compensation $ 0 $ 464 0 0 464          
Stock-based compensation (in shares) 0 0                
Dividends on common stock $ 0 $ 0 0 (2,824) (2,824)          
Dividends on common stock (in shares) 0 0                
Other comprehensive income (loss), net $ 0 $ 0 (245) 0 (245)          
Balance at Dec. 31, 2023 $ 0 $ 46,614 $ (1,016) $ 70,646 $ 116,244          
Balances (in shares) at Dec. 31, 2023 0 8,875,000     8,875,012          
[1] On January 1, 2023, the Company adopted the provisions of Accounting Standards Codification Topic 326. The allowance in 2023 is reported using the current expected credit loss (“CECL”) method. Periods prior to adoption are reported in accordance with previous GAAP using the incurred loss method.